| Serial Number | 97469034 |
| Word Mark | CTX330 |
| Filing Date | Tuesday, June 21, 2022 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, June 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 23, 2024 |
| Goods and Services | Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy |
| Pseudo Mark | CTX THREE THREE ZERO; CTX THREE HUNDRED THIRTY |
| Goods and Services | Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 6300 CH |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 6300 CH |
| Event Date | Event Description |
| Friday, March 31, 2023 | ASSIGNED TO EXAMINER |
| Friday, June 24, 2022 | NEW APPLICATION ENTERED |
| Friday, July 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 9, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 9, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 9, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 19, 2023 | ASSIGNED TO EXAMINER |
| Monday, October 2, 2023 | FINAL REFUSAL WRITTEN |
| Monday, October 2, 2023 | FINAL REFUSAL E-MAILED |
| Monday, October 2, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, December 18, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, December 18, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, February 27, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, February 27, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, March 16, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 23, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 18, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |